Wu X, Jiang D, Wang Y, Li X, Liu C, Chen Y
Hepatol Commun. 2024; 8(12).
PMID: 39621053
PMC: 11608672.
DOI: 10.1097/HC9.0000000000000585.
Guest R, Goeppert B, Nault J, Sia D
Am J Pathol. 2024; 195(3):345-361.
PMID: 39341365
PMC: 11841493.
DOI: 10.1016/j.ajpath.2024.08.014.
Wu Z, Liu D, Ou Y, Xu Z, Heng G, Liu W
Clin Transl Med. 2024; 14(3):e1622.
PMID: 38481381
PMC: 10938070.
DOI: 10.1002/ctm2.1622.
Madkor H, Abd El-Aziz M, El-Maksoud M, Ibrahim I, Ali F
Curr Diabetes Rev. 2024; 21(4):21-37.
PMID: 38173073
DOI: 10.2174/0115733998275428231210055650.
Singh S, Lian Q, Budiman T, Taketo M, Simons B, Gupta V
Dev Cell. 2023; 58(23):2732-2745.e5.
PMID: 37909044
PMC: 10842076.
DOI: 10.1016/j.devcel.2023.10.004.
A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans.
Zhang W, Wang X, Lanzoni G, Wauthier E, Simpson S, Ezzell J
NPJ Regen Med. 2023; 8(1):40.
PMID: 37528116
PMC: 10394089.
DOI: 10.1038/s41536-023-00303-5.
Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives.
Kuwatani M, Sakamoto N
Cancers (Basel). 2023; 15(14).
PMID: 37509347
PMC: 10378186.
DOI: 10.3390/cancers15143686.
Liver cell therapies: cellular sources and grafting strategies.
Zhang W, Cui Y, Du Y, Yang Y, Fang T, Lu F
Front Med. 2023; 17(3):432-457.
PMID: 37402953
DOI: 10.1007/s11684-023-1002-1.
Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects.
Chung G, Yu S, Yoo J, Cho Y, Lee K, Shin D
Cancer Commun (Lond). 2023; 43(8):863-876.
PMID: 37337385
PMC: 10397567.
DOI: 10.1002/cac2.12454.
β-adrenergic receptor agonist promotes ductular expansion during 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced chronic liver injury.
Tanimizu N, Ichinohe N, Mitaka T
Sci Rep. 2023; 13(1):7084.
PMID: 37127664
PMC: 10151327.
DOI: 10.1038/s41598-023-33882-w.
Role of the Gut-Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence.
Bragazzi M, Venere R, Vignone A, Alvaro D, Cardinale V
Int J Mol Sci. 2023; 24(7).
PMID: 37047635
PMC: 10095354.
DOI: 10.3390/ijms24076660.
Development of extrahepatic bile ducts and mechanisms of tumorigenesis: Lessons from mouse models.
Tomita H, Hara A
Pathol Int. 2022; 72(12):589-605.
PMID: 36349994
PMC: 10098476.
DOI: 10.1111/pin.13287.
Pitfalls and promises of bile duct alternatives: A narrative review.
Miyazawa M, Aikawa M, Takashima J, Kobayashi H, Ohnishi S, Ikada Y
World J Gastroenterol. 2022; 28(39):5707-5722.
PMID: 36338889
PMC: 9627420.
DOI: 10.3748/wjg.v28.i39.5707.
Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states.
Zhang W, Wauthier E, Lanzoni G, Hani H, Yi X, Overi D
Biomaterials. 2022; 288:121647.
PMID: 36030102
PMC: 10495116.
DOI: 10.1016/j.biomaterials.2022.121647.
Role of Immune Cells in Biliary Repair.
Lan T, Qian S, Tang C, Gao J
Front Immunol. 2022; 13:866040.
PMID: 35432349
PMC: 9005827.
DOI: 10.3389/fimmu.2022.866040.
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.
Vij M, Puri Y, Rammohan A, G G, Rajalingam R, Kaliamoorthy I
World J Gastrointest Oncol. 2022; 14(3):607-627.
PMID: 35321284
PMC: 8919011.
DOI: 10.4251/wjgo.v14.i3.607.
A framework for fibrolamellar carcinoma research and clinical trials.
Dinh T, Utria A, Barry K, Ma R, Abou-Alfa G, Gordan J
Nat Rev Gastroenterol Hepatol. 2022; 19(5):328-342.
PMID: 35190728
PMC: 9516439.
DOI: 10.1038/s41575-022-00580-3.
Islet Regeneration and Pancreatic Duct Glands in Human and Experimental Diabetes.
Overi D, Carpino G, Moretti M, Franchitto A, Nevi L, Onori P
Front Cell Dev Biol. 2022; 10:814165.
PMID: 35186929
PMC: 8855925.
DOI: 10.3389/fcell.2022.814165.
Patch grafting, strategies for transplantation of organoids into solid organs such as liver.
Zhang W, Lanzoni G, Hani H, Overi D, Cardinale V, Simpson S
Biomaterials. 2021; 277:121067.
PMID: 34517276
PMC: 8826591.
DOI: 10.1016/j.biomaterials.2021.121067.
Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening.
Pasqua M, Di Gesu R, Chinnici C, Conaldi P, Francipane M
Int J Mol Sci. 2021; 22(15).
PMID: 34360991
PMC: 8348238.
DOI: 10.3390/ijms22158227.